Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Delirium in Awake Craniotomies
NCT05195034Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2022
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative delirium (POD) comparing DEX group with Placebo group (2 arms). Primary endpoint: Incidence of postoperative delirium at 5 days. Started Mar 2022; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05195034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05195034.